TELO
Price:
$2.2
Market Cap:
$65.48M
Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human stem cells. It develops TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic intervention against age-related inflammatory conditions, such as hemochromatosis and osteoarthritis, as well as for post-chemotherapy recovery by interrupting and preventing the interleukin-17 induced inflammatory pathways. The company was formerly known as Metallo Therapies Inc. and changed its name to Telomir Pharmaceuticals, Inc. on October 10, 2022. Telomir Pharmaceuticals, Inc. was incorporated in 2021 and is head...[Read more]
Industry
Biotechnology
IPO Date
2019-04-09
Stock Exchange
NASDAQ
Ticker
TELO
According to Telomir Pharmaceuticals, Inc. Common Stock’s latest financial reports and current stock price. The company's current PE Ratio is -5.50. This represents a change of -57.00% compared to the average of -12.79 of the last 4 quarters.
The mean historical PE Ratio of Telomir Pharmaceuticals, Inc. Common Stock over the last ten years is -441.60. The current -5.50 PE Ratio has changed 24.55% with respect to the historical average. Over the past ten years (40 quarters), TELO's PE Ratio was at its highest in in the December 2023 quarter at -5.56. The PE Ratio was at its lowest in in the March 2022 quarter at -816.15.
Average
-441.60
Median
-129.26
Minimum
-1500.52
Maximum
-7.36
Discovering the peaks and valleys of Telomir Pharmaceuticals, Inc. Common Stock PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = -7.36
Minimum Annual Increase = -93.47%
Minimum Annual PE Ratio = -1500.52
Year | PE Ratio | Change |
---|---|---|
2024 | -7.36 | -53.57% |
2023 | -15.86 | -93.47% |
2022 | -242.66 | -83.83% |
The current PE Ratio of Telomir Pharmaceuticals, Inc. Common Stock (TELO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-88.63
5-year avg
-441.60
10-year avg
-441.60
Telomir Pharmaceuticals, Inc. Common Stock’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Telomir Pharmaceuticals, Inc. Common Stock using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Telomir Pharmaceuticals, Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Telomir Pharmaceuticals, Inc. Common Stock's PE Ratio?
How is the PE Ratio calculated for Telomir Pharmaceuticals, Inc. Common Stock (TELO)?
What is the highest PE Ratio for Telomir Pharmaceuticals, Inc. Common Stock (TELO)?
What is the 3-year average PE Ratio for Telomir Pharmaceuticals, Inc. Common Stock (TELO)?
What is the 5-year average PE Ratio for Telomir Pharmaceuticals, Inc. Common Stock (TELO)?
How does the current PE Ratio for Telomir Pharmaceuticals, Inc. Common Stock (TELO) compare to its historical average?